Symphony Environmental Technologies FDA Approval opens wider opportunities (Interview)

Symphony Environmental Technologies plc (LON:SYM) CFO Ian Bristow joins DirectorsTalk to discuss approval from the U.S. Food & Drug Administration for its d2p antimicrobial food contact technology. Ian explains what this means for the company, the market value they are now targeting, other regions now being targeted and what else investors can look out for over the coming months.

Symphony Environmental Technologies is a world leader in the development of additives to make ordinary plastic biodegradable, and protective technologies to enhance plastic products.

You might also enjoy reading  Symphony Environmental Health Canada approves d2p AM masterbatch for bread packaging
Find more news, interviews, share price & company profile here for:
Symphony Environmental Technologies Plc

Share this interview

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp